New hope for elderly lung cancer patients: combined surgery and rehab study launches

NCT ID NCT07632664

Recruiting now Disease control Sponsor: Peking University People's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 16, 2026 · Updated 3 times

Summary

This study is testing a new treatment model for elderly patients (65+) with early-stage lung cancer. It combines advanced surgical techniques, personalized care before and after surgery, and rehabilitation programs. The goal is to improve survival and reduce complications. Researchers will enroll 1,000 participants across multiple centers in China.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Surgery (lobectomy or segmentectomy) plus perioperative care and rehabilitation
What this could lead to: If successful, this could establish a safer, more effective treatment pathway for elderly lung cancer patients, potentially improving survival and quality of life.
What could go wrong: This is an early-stage study without a control group, so results may not prove the new model is better than standard care. Risks include surgical complications and the challenges of treating older patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGED LUNG NEOPLASM PERIOPERATIVE CARE POSTOPERATIVE REHABILITATION THORACIC SURGICAL PROCEDURES

Contacts and locations

Locations

Peking University People's Hospital
RECRUITING

Beijing, Beijing Municipality, 100044, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.